PubRank

R N Rosenberg

Author PubWeight™ 78.21‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Alzheimer's disease and its Lewy body variant: a clinical analysis of postmortem verified cases. Am J Psychiatry 1996 2.30
2 Vasoactive intestinal polypeptide: abundant immunoreactivity in neural cell lines and normal nervous tissue. Science 1976 1.76
3 DNA-triplet repeats and neurologic disease. N Engl J Med 1996 1.60
4 Competent patients with advanced states of permanent paralysis have the right to forgo life-sustaining therapy. Neurology 1993 1.58
5 Familial opticoacoustic nerve degeneration and polyneuropathy. Neurology 1967 1.50
6 Category fluency in mild cognitive impairment: reduced effect of practice in test-retest conditions. Alzheimer Dis Assoc Disord 2004 1.48
7 Peripheral neuropathy and starvation after gastric partitioning for morbid obesity. Ann Intern Med 1982 1.31
8 Correlation of double-minute chromosomes with unstable multidrug cross-resistance in uptake mutants of neuroblastoma cells. Proc Natl Acad Sci U S A 1981 1.28
9 Autosomal dominant striatonigral degeneration. A clinical, pathologic, and biochemical study of a new genetic disorder. Neurology 1976 1.27
10 Markers for gene expression in cultured cells from the nervous system. J Biol Chem 1972 1.26
11 Transverse myelitis associated with heroin addiction. JAMA 1968 1.22
12 Autosomal dominant cerebellar phenotypes: the genotype has settled the issue. Neurology 1995 1.21
13 Effects of practice on category fluency in Alzheimer's disease. Clin Neuropsychol 2001 1.20
14 Apoptosis and neurologic disease. Am J Med 2000 1.17
15 Mononeuritis multiplex in lepromatous leprosy. Arch Neurol 1968 1.12
16 Neurologic involvement in Urbach-Wiethe's disease (lipoid proteinosis). A clinical, ultrastructural, and chemical study. Neurology 1971 1.07
17 Platelet APP isoform ratios correlate with declining cognition in AD. Neurology 2000 1.01
18 Olivopontocerebellar degeneration. Clinical and ultrastructural abnormalities. Arch Neurol 1974 1.01
19 Comparison of the hopkins verbal learning test-revised to the California verbal learning test in Alzheimer's disease. Appl Neuropsychol 2001 1.00
20 Neurological complications of fibrous dysplasia of the skull. Arch Neurol 1968 0.99
21 Joseph's disease: an autosomal dominant neurological disease in the Portuguese of the United States and the Azores Islands. Adv Neurol 1978 0.97
22 The natural history of Machado-Joseph disease. An analysis of 138 personally examined cases. Can J Neurol Sci 1984 0.97
23 Creatine kinase BB isoenzyme levels by radioimmunoassay in patients with neurological disease. Ann Neurol 1978 0.97
24 Glial tumor metastases through a ventriculo-pleural shunt. Resultant massive pleural effusion. Arch Neurol 1968 0.94
25 The Machado-Joseph disease locus is different from the spinocerebellar ataxia locus (SCA1). Genomics 1992 0.94
26 Apolipoprotein E epsilon 4, other risk factors, and course of Alzheimer's disease. Biol Psychiatry 1999 0.91
27 Vasoactive intestinal polypeptide in brain synaptosomes. Lancet 1976 0.91
28 Progressive ophthalmoplegia. Report of cases. Arch Neurol 1968 0.90
29 Joseph disease: an autosomal dominant motor system degeneration. Adv Neurol 1984 0.90
30 Prion proteins: a biological role beyond prion diseases. Acta Neurol Scand 2007 0.90
31 Differences in the distribution of poly(A) size classes in individual messenger RNAs from neuroblastoma cells. J Biol Chem 1979 0.89
32 Physiology of glia: glial-neuronal interactions. Int Rev Neurobiol 1979 0.88
33 Frontal lobe ataxia. Surg Neurol 1995 0.87
34 Experimental chemotherapy of neuroblastoma. II. Increased thymidylate synthetase activity in a 5-fluorodeoxyuridine-resistant variant of mouse neuroblastoma. Mol Pharmacol 1975 0.86
35 A radioisotopic, chromatographic microassay for acetyl-coenzyme A synthetase and some preliminary studies on the rat brain enzyme. Biochim Biophys Acta 1973 0.85
36 Correlation of statin-increased platelet APP ratios and reduced blood lipids in AD patients. Neurology 2003 0.85
37 Induction of adenosine 3',5'-monophosphate binding proteins by N6,O2'-dibutyryladenosine 3',5'-monophosphate in mouse neuroblastoma cells. Analysis by two-dimensional gel electrophoresis. Biochemistry 1979 0.84
38 Altered apolipoprotein E secretion in cytokine treated human astrocyte cultures. J Neurol Sci 1997 0.84
39 Autosomal dominant progressive syndrome of motor-speech loss without dementia. Neurology 1997 0.84
40 Glutamate and malate dehydrogenase activities in Joseph disease and olivopontocerebellar atrophy. Neurology 1987 0.83
41 Serum antibodies to cytomegalovirus in myasthenia gravis: effects of thymectomy and steroids. Neurology 1978 0.83
42 Machado Joseph disease maps to the same region of chromosome 14 as the spinocerebellar ataxia type 3 locus. J Med Genet 1995 0.82
43 Specific messenger RNA changes in Joseph disease cerebella. Ann Neurol 1983 0.82
44 Regulation of the synthesis of choline-O-acetyltransferase and thymidylate synthetase in mouse neuroblastoma in cell culture. Proc Natl Acad Sci U S A 1971 0.82
45 Hypothermia and persisting capacity to develop fever. Occurrence in a patient with sarcoidosis of the central nervous system. Arch Neurol 1977 0.81
46 Idiopathic polyneuropathy associated with cytotoxic anti-neuroblastoma serum. IgG and IgM immunoglobulin studies. Neurology 1975 0.81
47 A comparison of thymidylate synthetase activities from 5-fluorodeoxyuridine sensitive and resistant variants of mouse neuroblastoma. J Neurochem 1975 0.81
48 Furosemide-sensitive K+ channel in glioma cells but not neuroblastoma cells in culture. Biochem Biophys Res Commun 1982 0.81
49 Quantitation and characterisation of poly(A)-containing messenger RNAs from mouse neuroblastoma cells. Biochim Biophys Acta 1977 0.81
50 Altered thymidine kinase or thymidylate synthetase activities in 5-fluoro deoxyuridine resistant variants of mouse neuroblastoma. J Neurochem 1977 0.81
51 Reye's syndrome: isolation of parainfluenza virus. Report of three cases. Arch Neurol 1973 0.81
52 Joseph disease and Huntington disease: protein patterns in fibroblasts and brain. Neurology 1981 0.80
53 Induction of cyclic AMP-binding proteins by dibutyryl cyclic AMP in mouse neuroblastoma cells. Biochim Biophys Acta 1978 0.80
54 An AP-2 binding sequence within exon 1 of human and porcine choline acetyltransferase genes enhances transcription in neural cells. Neuroscience 1997 0.80
55 Quinazoline antifolates as inhibitors of growth, dihydrofolate reductase, and thymidylate synthetase of mouse neuroblastoma cells in culture. Mol Pharmacol 1974 0.79
56 Xenon-133 SPECT-determined regional cerebral blood flow in Alzheimer's disease: what is typical? J Neuropsychiatry Clin Neurosci 1993 0.79
57 alpha-L-iduronidase deficiency and possible Hurler-Scheie genetic compound. Clinical, pathologic, and biochemical findings. Neurology 1976 0.79
58 Sleep apnea and hypoventilation syndrome associated with acquired nonprogressive dysautonomia: clinical and pathological studies in a child. Ann Neurol 1981 0.79
59 Molecular genetics, recombinant DNA techniques, and genetic neurological disease. Ann Neurol 1984 0.79
60 Recombinant DNA and neurologic disease: the coming of a new age. Neurology 1983 0.78
61 Molecular neurogenetics: the genome is settling the issue. JAMA 1997 0.78
62 Amplification signals anticipation--less DNA is better. Neurology 1992 0.78
63 Effect of dopamine agonist (Lergotrile mesylate) therapy on twenty-four hour secretion of prolactin in treated Parkinson's disease. J Clin Endocrinol Metab 1978 0.78
64 Decreased 6-mercaptopurine retention by two resistant variants of mouse neuroblastoma with normal hypoxanthine-guanine-phospho-ribosyltransferase activities. J Pharmacol Exp Ther 1975 0.78
65 Comparison of the CERAD and CVLT list-learning tasks in Alzheimer's disease. Clin Neuropsychol 2000 0.78
66 Machado Joseph disease is not an allele of the spinocerebellar ataxia 2 locus. Hum Genet 1994 0.77
67 Platelet APP isoform ratios in asymptomatic young adults expressing an AD-related presenilin-1 mutation. J Neurol Sci 2001 0.76
68 Aging and Alzheimer's disease: lessons from the Nun Study. Gerontologist 1998 0.76
69 Urine vapor pattern for olivopontocerebellar degeneration. Clin Biochem 1975 0.76
70 Memory loss--when is it Alzheimer disease? JAMA 1998 0.76
71 The 1990s--decade of the brain: the need for a national priority. Neurology 1990 0.76
72 Genomic neurology: a new beginning. Arch Neurol 2001 0.76
73 Morphological differentiation and proteoglycan synthesis regulate Alzheimer amyloid precursor protein processing in PC-12 and human astrocyte cultures. J Neurosci Res 1992 0.76
74 Erroneous diagnosis corrected after 28 years. Not spinal muscular atrophy with ophthalmoplegia but minicore myopathy. Arch Neurol 1996 0.76
75 Increased release of an amyloidogenic C-terminal Alzheimer amyloid precursor protein fragment from stressed PC-12 cells. J Neurosci Res 1991 0.76
76 Neurotherapeutics, evidence-based neurology, and clinical equipoise. Arch Neurol 1999 0.76
77 Idiopathic acute symmetrical polyradiculoneuritis. The Landry-Guillain-Barré-Strohl syndrome. West J Med 1974 0.75
78 Spinocerebellar ataxias and ataxins. N Engl J Med 1995 0.75
79 Defining the neurological basis of the Gulf War syndrome. Arch Neurol 2000 0.75
80 An anonymous single copy clone (p1,2-2) from a flow sorted human chromosomes 1 and 2 library (D1S33). Nucleic Acids Res 1987 0.75
81 Presidential judgment. The twenty-fifth amendment. Arch Neurol 1997 0.75
82 The triumph of linkage analysis. Ann Neurol 1990 0.75
83 Effect of norepinephrine on glucose metabolism in glioblastoma and neuroblastoma cells in cell culture. Proc Natl Acad Sci U S A 1972 0.75
84 Treatment of cerebral edema. Calif Med 1971 0.75
85 The interrelationship of neurofibromatosis and fibrous dysplasia. Arch Neurol 1967 0.75
86 Alternative neurology. Arch Neurol 1998 0.75
87 Autosomal dominant striatonigral degeneration: a clinical, pathological, and biochemical study of a new genetic disorder. Trans Am Neurol Assoc 1976 0.75
88 Differentiation of neuroblastoma, glioma, and hybrid cells in culture as measured by the synthesis of specific protein species: evidence for neuroblast-glioblast reciprocal genetic regulation. J Neurochem 1978 0.75
89 Glial genes for the regulation of neuronal protein synthesis: evidence for a biochemical unit and its clinical implications. Trans Am Neurol Assoc 1979 0.75
90 CK-BB isoenzyme detected by radioimmunoassay. Ann Neurol 1978 0.75
91 Autosomal dominant motor system disease of the Portuguese: a review. Neurology 1981 0.75
92 Reporting clinical trials: full access to all the data. Neurology 2002 0.75
93 Reporting clinical trials: full access to all the data. Stroke 2001 0.75
94 Postscript: criteria for accepting a biochemical defect as primary. Adv Neurol 1978 0.75
95 Inverse relationship of the velocities of perceived time and information processing events in the brain: a potential bioassay for neural functions: a hypothesis. Med Hypotheses 1979 0.75
96 Myasthenia gravis. Calif Med 1973 0.75
97 Reporting clinical trials: full access to all the data. Neurorehabil Neural Repair 2001 0.75
98 Nicotinic acetylcholine receptor of mammalian brain: naja toxin binding to subcellular fractions of rat brain. J Neurochem 1978 0.75
99 An introduction to the molecular genetics of neurological disease. Recent advances. Arch Neurol 1993 0.75
100 Phosphorus 31 NMR of neuroblastoma clonal lines. Effect of cell confluency state and dibutyryl cyclic AMP. Neurochem Res 1979 0.75
101 Dominant ataxias. Res Publ Assoc Res Nerv Ment Dis 1983 0.75
102 At jeopardy: the NIH as we know it. J Neurol Sci 2003 0.75
103 Encephalopathy associated with cryoprecipitable Australia antigen. Ann Neurol 1977 0.75
104 Neuroblastoma and glioma cell cultures in studies of neurologic functions: the clinician's Rosetta Stone? Neurology 1977 0.75
105 Mitochondria in evolution and disease. J Child Neurol 1994 0.75
106 Joseph disease: protein patterns in fibroblasts and brain. Neurology 1979 0.75
107 Cerebral control of speech. N Engl J Med 1968 0.75
108 Encephalopathy and fatty degeneration of viscera. Lancet 1972 0.75
109 Dopa as an antimetabolite in Huntington's disease. Lancet 1973 0.75
110 Frequent alterations of specific reiterated DNA sequence abundances in human cancer. Cancer Genet Cytogenet 1987 0.75
111 The search for a physiologic marker of Machado-Joseph disease. Neurology 1987 0.75
112 Continuing medical education in neurology: an archives of neurology initiative. Arch Neurol 1999 0.75
113 Kinetics of acetylcholine synthesis and hydrolysis in myasthenia gravis. Science 1971 0.75
114 Nobel Prize in Physiology or Medicine for 1997 Awarded to Stanley B. Prusiner, MD. Arch Neurol 1997 0.75
115 Genomic medicine and the individual patient--byte to bedside: A call for papers. JAMA 2000 0.75
116 Oral-facial dyskinesia and quadriplegia associated with poliomyelitis virus type 3. Am J Dis Child 1973 0.75
117 Primary (neurogenic) alveolar hypoventilation. A case report and review of the literature. Arch Neurol 1966 0.75
118 Reporting clinical trials: full access to all the data. J Neurol Neurosurg Psychiatry 2002 0.75
119 Amyotrophy in multisystem genetic diseases. Adv Neurol 1982 0.75
120 The synthesis and degradation of poly(a)-containing mRNAs in mouse neuroblastoma cells treated with dibutyryl cAMP or with Ro20-1724. J Neurochem 1980 0.75
121 Mononeuritis multiplex in lepromatous leprosy. Neurology 1968 0.75
122 Autosomal dominant neurological disorders. Ann Neurol 1978 0.75
123 Biochemical genetics of neurologic disease. N Engl J Med 1981 0.75
124 Neuro-oncology 1999. Arch Neurol 1999 0.75
125 Glucose metabolism in mixed glioblastoma and neuroblastoma cultures. Biochem Biophys Res Commun 1973 0.75
126 Choline acetyltransferase and acetylcholinesterase. Their role in the causes of myasthenia gravis. Arch Neurol 1972 0.75
127 Neuronal and glial enzyme studies in cell culture. In Vitro 1973 0.75
128 The Guillain-Barré syndrome. A discussion of current concepts. Wis Med J 1966 0.75
129 The brain code in health and disease. Arch Neurol 2000 0.75
130 Thermolability in Wernicke's encephalopathy. Arch Neurol 1978 0.75
131 Comparison of ribosomal subunit proteins from normal human and Huntington's disease skin fibroblasts. Ann Neurol 1977 0.75
132 Accumulation of 131 I-labeled albumin in a subdural hematoma demonstrated by cisternography. J Nucl Med 1971 0.75